Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 255 citing articles:

Role of Hematological Parameters in Covid-19 Patients in the Emergency Room
Eren Usul, İshak Şan, Burak Bekgöz, et al.
Biomarkers in Medicine (2020) Vol. 14, Iss. 13, pp. 1207-1215
Open Access | Times Cited: 144
Prognostic value of the pretreatment systemic immune-inflammation index in patients with prostate cancer: a systematic review and meta-analysis
Linghao Meng, Yujia Yang, Xu Hu, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 70
Association between the systemic immune-inflammation index and kidney stone: A cross-sectional study of NHANES 2007-2018
Xingpeng Di, Shaozhuang Liu, Liyuan Xiang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 59
Association between systemic immune-inflammation index and chronic obstructive pulmonary disease: a population-based study
Chenglin Ye, Yuan Li, Kailang Wu, et al.
BMC Pulmonary Medicine (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 56
Association between systemic immune-inflammation index and psoriasis: a population-based study
Xiya Zhao, Junqin Li, Xinhua Li
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 15
Clinically relevant prognostic and predictive markers for immune-checkpoint-inhibitor (ICI) therapy in non-small cell lung cancer (NSCLC)
Wolfgang M. Brueckl, Joachim H. Ficker, Gloria Zeitler
BMC Cancer (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 121
Predictive value of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in non-small cell lung cancer patients treated with immune checkpoint inhibitors: A meta-analysis
Na Zhang, Jianjun Jiang, Sihui Tang, et al.
International Immunopharmacology (2020) Vol. 85, pp. 106677-106677
Closed Access | Times Cited: 86
Pretreatment Neutrophil-to-Lymphocyte Ratio (NLR) May Predict the Outcomes of Advanced Non-small-cell Lung Cancer (NSCLC) Patients Treated With Immune Checkpoint Inhibitors (ICIs)
Ye Li, Zhibo Zhang, Yi Hu, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 76
Role of hematological parameters in the diagnosis of influenza virus infection in patients with respiratory tract infection symptoms
Qingzhen Han, Xiaomin Wen, Lin Wang, et al.
Journal of Clinical Laboratory Analysis (2020) Vol. 34, Iss. 5
Open Access | Times Cited: 71
Inflammation and cancer: paradoxical roles in tumorigenesis and implications in immunotherapies
Xinghan Liu, Lijie Yin, Sunan Shen, et al.
Genes & Diseases (2021) Vol. 10, Iss. 1, pp. 151-164
Open Access | Times Cited: 68
Systemic Immune–Inflammation Index Predicts Prognosis of Cancer Immunotherapy: Systemic Review and Meta-Analysis
Bao‐Wen Tian, Yafei Yang, Chuncheng Yang, et al.
Immunotherapy (2022) Vol. 14, Iss. 18, pp. 1481-1496
Closed Access | Times Cited: 66
Systemic inflammation and pro-inflammatory cytokine profile predict response to checkpoint inhibitor treatment in NSCLC: a prospective study
Diego Kauffmann‐Guerrero, Kathrin Kahnert, Rosemarie Kiefl, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 58
Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Prognostic Markers for Advanced Non-Small-Cell Lung Cancer Treated with Immunotherapy: A Systematic Review and Meta-Analysis
Hesti Platini, Eric Ferdinand, Kelvin Kohar, et al.
Medicina (2022) Vol. 58, Iss. 8, pp. 1069-1069
Open Access | Times Cited: 52
Predictive Value of Systemic Immune-Inflammation index and Neutrophil-to-Lymphocyte Ratio in Patients with Severe COVID-19
Wei Xia, Yafeng Tan, Shengmei Hu, et al.
Clinical and Applied Thrombosis/Hemostasis (2022) Vol. 28
Open Access | Times Cited: 42
The relationship between NLR/PLR/LMR levels and survival prognosis in patients with non-small cell lung carcinoma treated with immune checkpoint inhibitors
Na Liu, Jinmei Mao, Peizhi Tao, et al.
Medicine (2022) Vol. 101, Iss. 3, pp. e28617-e28617
Open Access | Times Cited: 41
Prognostic Values of Systemic Inflammatory Immunological Markers in Glioblastoma: A Systematic Review and Meta-Analysis
Paweł Jarmużek, Klaudia Kozłowska, Piotr Defort, et al.
Cancers (2023) Vol. 15, Iss. 13, pp. 3339-3339
Open Access | Times Cited: 40
Prognostic Significance of the Systemic Immune-Inflammation Index (SII) in Patients With Small Cell Lung Cancer: A Meta-Analysis
Yuting Zhou, Menglu Dai, Zongxin Zhang
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 38
The Relationship Between Systemic Immune Inflammatory Index and Prognosis of Patients With Non-Small Cell Lung Cancer: A Meta-Analysis and Systematic Review
Wei Huang, Jiayu Luo, Jianbo Wen, et al.
Frontiers in Surgery (2022) Vol. 9
Open Access | Times Cited: 38
Peripheral blood inflammatory biomarkers dynamics reflect treatment response and predict prognosis in non‐small cell lung cancer patients with neoadjuvant immunotherapy
Qilin Huai, Chenyu Luo, Peng Song, et al.
Cancer Science (2023) Vol. 114, Iss. 12, pp. 4484-4498
Open Access | Times Cited: 30
The prognostic predictive value of systemic immune index and systemic inflammatory response index in nasopharyngeal carcinoma: A systematic review and meta-analysis
Li Wang, Xianfei Qin, Yu Zhang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 24
Pretreatment neutrophil-to-lymphocyte ratio is associated with immunotherapy efficacy in patients with advanced cancer: a systematic review and meta-analysis
Jialin Su, Li Yu-ning, Shuhua Tan, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Prognostic value of systemic immune-inflammation index in patients with small-cell lung cancer treated with immune checkpoint inhibitors
Yusuke Hamakawa, Ayumi Hirahara, Akiko Hayashi, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Triple-negative breast cancer modifies the systemic immune landscape and alters neutrophil functionality
Noor A. M. Bakker, Hannah Garner, Ewald van Dyk, et al.
npj Breast Cancer (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 1
EPSILoN: A Prognostic Score for Immunotherapy in Advanced Non-Small-Cell Lung Cancer: A Validation Cohort
Arsela Prelaj, Roberto Ferrara, Sara Elena Rebuzzi, et al.
Cancers (2019) Vol. 11, Iss. 12, pp. 1954-1954
Open Access | Times Cited: 70
Page 1 - Next Page

Scroll to top